Open mobile menu
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

A To Z Drugs In Highlight T Is For TECFIDERA®

A to Z: Drugs in Highlight: T is for TECFIDERA®

News A to Z Feature 17/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is T is for TECFIDERA. TECFIDERA (from Biogen) is a disease modifying therapy used for treating people with relapsing-remitting Multiple Sclerosis (MS).

Read more
Court Decision
European, Industry news, News 09/06/2015

Changes to Rule 164 EPC - Good News for Applicants

HROBSON - Secerna
News, Team news 15/04/2014

Secerna LLP Expands its Chemistry and Pharmaceutical Team

Money 13.02.18
European, Industry news 11/03/2014

Filing EP Divisional Patent Applications

Newcastle Central Station [Unsplash]
News, Team news 03/03/2014

Secerna LLP Opens a Newcastle Office

LED Blue Light
Industry news, News 18/02/2014

Designers Pay Litigation Damages

Istock 000006004177Small
Industry news, News 14/01/2014

Patent Term Extension in the US Clarified

34 35 36 37 38 39